Zimmer Biomet Holdings (ZBH) Operating Margin (2009 - 2026)

Zimmer Biomet Holdings' Operating Margin history runs 18 years deep, the most recent figure standing at 17.88% for Q1 2026.

• On a quarterly basis, Operating Margin rose 257.0% year-over-year to 17.88% in Q1 2026; TTM through Mar 2026 was 14.02%, a 302.0% decrease from a year earlier, with the FY2025 full-year figure at 13.34%, down 340.0% from the prior year.
• Operating Margin grew to 17.88% in Q1 2026 per ZBH's latest filing, from 6.89% in the prior quarter.
• Across five years, Operating Margin topped out at 19.23% in Q4 2024 and bottomed at 1.55% in Q4 2022.
• The 5-year median for Operating Margin is 15.32% (2024), against an average of 14.62%.
• Across the five-year window, Operating Margin jumped 1981 bps in 2023 and tumbled 1234 bps in 2025, its largest moves.
• Year by year, Operating Margin stood at 1.55% in 2022, then surged by 1277 bps to 18.26% in 2023, then increased by 5 bps to 19.23% in 2024, then sank by 64 bps to 6.89% in 2025, then surged by 160 bps to 17.88% in 2026.
• Per Business Quant, the three latest ZBH Operating Margin figures stand at 17.88% (Q1 2026), 6.89% (Q4 2025), and 17.55% (Q3 2025).